Targeted protease inhibition (KLK5/KLK7 blockade): If someone has Netherton syndrome, it means they lack the LEKTI protein, which leads to KLK5 and KLK7 acting uncontrollably and causing the skin barrier to break and become inflamed. The gene discussed is KLK5; the disease is Netherton syndrome.